Form 4: Allovir CFO Vikas Sinha Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


Vikas Sinha, CFO of Allovir, sold shares to cover tax withholding obligations related to vesting restricted stock units.

Summary

  • Vikas Sinha, the President and CFO of Allovir, Inc., filed a Form 4 detailing changes in beneficial ownership.
  • On November 5, 2024, Sinha sold 5,136 shares of common stock at a price of $0.8649 per share to cover tax withholding obligations related to the vesting of restricted stock units.
  • Following the transaction, Sinha directly owns 1,144,080 shares of Allovir common stock.
  • Sinha also indirectly owns 16,674,766 shares through ElevateBio LLC, where he serves as a director and CFO.
  • Sinha disclaims beneficial ownership of these shares except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: Neutral sentiment as the filing simply reports a routine transaction to cover tax obligations.

Industry Context

Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to investors.

Stakeholder Impact

  • The sale of shares by an insider could have a minor negative impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates

DateDescription
11/05/2024Date of the share sale transaction.
11/06/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.